• Radiation Therapy
      • Treatment Delivery
        • Elekta Unity Elekta Unity
        • Versa HD Versa HD
        • Elekta Harmony Elekta Harmony
        • Elekta Infinity Elekta Infinity
        • Elekta Synergy Elekta Synergy
      • Treatment Management
        • Monaco
        • ProKnow
      • Quality Assurance
        • Machine QA
        • Patient QA
    • Stereotactic Radiosurgery
      • Delivery
        • Elekta Esprit Elekta Esprit
        • Leksell Gamma Knife Icon Leksell Gamma Knife Icon
        • Leksell Gamma Knife Perfexion Leksell Gamma Knife Perfexion
        • Versa HD Versa HD
      • Treatment Planning
        • Leksell Gamma Knife Lightning
        • Leksell GammaPlan
    • Oncology Informatics
      • MOSAIQ Plaza
        • Subscribe to Better
        • Professional Services
        • Interoperability
      • Elekta Axis Cloud
    • Brachytherapy
      • Delivery
        • Elekta Studio Elekta Studio
        • ImagingRing ImagingRing
        • Oncentra Brachy Oncentra Brachy
        • Venezia Venezia
        • Flexitron Flexitron
        • Geneva Geneva
      • Body Sites
        • Head and Neck
        • Bronchus and Oesophagus
        • Breast
        • Skin
        • Prostate
        • Rectum
        • Bladder
        • Gynecology
    • Neurosurgery
      • Delivery
        • Leksell Vantage Stereotactic System Leksell Vantage Stereotactic System
        • Leksell Stereotactic System Leksell Stereotactic System
    • Veterinary Radiation Therapy
    • Elekta Care Customer Services
    • Elekta Care 360
    • Elekta Care Learning
    • Elekta Care Community
    • Elekta Partner Community
    • MR-Linac Treatment
    • Brachytherapy Treatment
    • Gamma Knife Treatment
    • Radiation Therapy Treatment
    • Treatment Centers
    • Company
    • Partnering with Elekta
    • About us
      • About us
        • Board of Directors
        • Code of Conduct
        • Corporate Citizenship
        • Executive Management
        • Integrity Line
        • Programs
        • Sponsorship and Donation
        • Story
    • Sustainability
    • Corporate Governance
      • Corporate Governance
        • Shareholders’ meetings
          • Board of Directors
            • Executive Management
              • Auditors
              • Reports
          • Investors
            • Investors
              • Investment case
                • Outlook
                • The share
                  • Financials
                    • Funding
                      • Reports & presentations
                      • Press releases
                      • IR calendar
                      • IR contacts
                  • Newsroom
                    • Newsroom
                      • Press Releases
                      • FOCUS Magazine
                      • Events
                      • Image bank
                  • Careers at Elekta
                    • Jobs
                  • Reimbursement Support & Policy
                ENSV
                Login
                • Products
                  • Radiation Therapy
                    • Treatment Delivery
                      • Elekta Unity
                      • Versa HD
                      • Elekta Harmony
                      • Elekta Infinity
                      • Elekta Synergy
                    • Treatment Management
                      • Monaco
                      • ProKnow
                    • Quality Assurance
                      • Machine QA
                      • Patient QA
                  • Stereotactic Radiosurgery
                    • Delivery
                      • Elekta Esprit
                      • Leksell Gamma Knife Icon
                      • Leksell Gamma Knife Perfexion
                    • Treatment Planning
                      • Leksell Gamma Knife Lightning
                      • Leksell GammaPlan
                    • Versa HD
                  • Oncology Informatics
                    • MOSAIQ Plaza
                      • Subscribe to Better
                      • Professional Services
                      • Interoperability
                    • Elekta Axis Cloud
                  • Brachytherapy
                    • Elekta Studio
                    • ImagingRing
                    • Venezia
                    • Flexitron
                    • Geneva
                    • Head and Neck
                    • Bronchus and Oesophagus
                    • Breast
                    • Skin
                    • Prostate
                    • Rectum
                    • Bladder
                    • Gynecology
                    • Oncentra Brachy
                  • Neurosurgery
                    • Leksell Vantage Stereotactic System
                    • Leksell Stereotactic System
                  • Veterinary Radiation Therapy
                • Services
                  • Elekta Care Customer Services
                  • Elekta Care 360
                  • Elekta Care Learning
                  • Elekta Care Community
                  • Elekta Partner Community
                • Patients
                  • MR-Linac Treatment
                  • Brachytherapy Treatment
                  • Gamma Knife Treatment
                  • Radiation Therapy Treatment
                  • Treatment Centers
                • Company
                  • Partnering with Elekta
                  • About us
                    • Board of Directors
                    • Code of Conduct
                    • Corporate Citizenship
                    • Executive Management
                    • Integrity Line
                    • Programs
                    • Sponsorship and Donation
                    • Story
                  • Sustainability
                  • Corporate Governance
                    • Shareholders’ meetings
                      • Board of Directors
                        • Executive Management
                          • Auditors
                          • Reports
                        • Investors
                          • Investment case
                            • Outlook
                            • The share
                              • Financials
                                • Funding
                                  • Reports & presentations
                                  • Press releases
                                  • IR calendar
                                  • IR contacts
                                • Newsroom
                                  • Press Releases
                                  • FOCUS Magazine
                                  • Events
                                  • Image bank
                                • Careers at Elekta
                                  • Jobs
                                • Reimbursement Support & Policy
                              • Contact
                              • Medical Affairs
                              • Regulatory Affairs
                              • Suppliers
                                • About Elekta Procurement
                                • Sustainable Sourcing
                                • Performance Management
                                  • Production Part Approval Process
                                  • Supplier Escalation Form
                                  • Non Conformance Management
                                  • Supplier Performance Management
                                  • Obsolescence Management
                                • Compliance Management
                                • Invoicing Process
                                • Elekta T&C
                                • Documents & Training
                                • Our Global Presence
                              • Facebook
                              • LinkedIn
                              • Twitter
                              • Instagram
                              • Youtube

                              Elekta’s climate targets validated by the Science Based Targets initiative (SBTi)

                              February 24, 2023

                              STOCKHOLM – Elekta (EKTA-B.ST) has received validation of its commitment to reduce its greenhouse gas emissions. The Science Based Targets initiative (SBTi) – a partnership between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF) – has validated Elekta’s targets.

                              Gustaf Salford, CEO of Elekta, said: “Elekta has set an ambitious roadmap for reducing emissions in line with the Paris Agreement and aligning our operations with climate science. Sustainability is fundamental to our strategy and this validation by SBTi confirms that we’re on track to minimizing our environmental footprint while maximizing social value.”

                              Hilma Nordquist, Elekta’s Group Sustainability Director, added: “One of our targets is to reduce greenhouse gas emissions per cancer treatment course* delivered with Elekta’s products. This target was chosen to decrease the environmental footprint of Elekta’s activity within the context of a growing cancer burden that will require more treatments. By tracking emissions per cancer treatment course, we promote more environmentally efficient solutions to treat cancer globally in order to tackle the increase in cases. This goal supports our journey for a more sustainable future.”

                              The Intergovernmental Panel on Climate Change has clearly warned that the world faces unavoidable multiple climate hazards over the next two decades due to the impact of global warming and climate change. Elekta is striving to support the necessary green transition through, among other actions, its science-based targets such as:
                               
                              For Scope 1(1) (including direct emissions from Elekta’s own operations) and Scope 2(2) (including indirect emissions from purchased electricity and district heating), Elekta shall reduce absolute emissions by 46.2 percent by end of fiscal year 2031/32.
                               
                              For Scope 2 (including indirect emissions from purchased electricity and district heating) Elekta shall transition to 100 percent renewable electricity by end of 2030.
                               
                              In Scope 3(3) (including indirect emissions occurring across our value chain) Elekta has two targets, one involving the use of our products and one involving suppliers:

                              • Use of products: Emissions from the use and end-of-life processing of Elekta’s products shall be reduced by 55 percent per radiotherapy treatment course by end of fiscal year 2031/32.
                              • Suppliers: Elekta shall engage a proportion of suppliers to have science-based targets by the end of fiscal year 2026/27. The target proportion corresponds to 27.5 percent of emissions from suppliers. 

                               (1), (2) Scope 1 (direct emissions) and Scope 2 (indirect emissions from purchased energy) cover emissions across the company’s operations.
                              (3) Scope 3 refers to indirect value chain emissions.
                               
                              *A radiotherapy treatment course is defined as a full radiotherapy treatment for an individual, which can consist of one or more treatment sessions. 
                               
                              Read more about how Elekta is actively committed to global sustainability at https://www.elekta.com/company/sustainability/
                              Read more about Science Based Targets initiative

                              # # #
                               
                              For further information, please contact:
                              Mattias Thorsson, Vice President, Head of Corporate Communications
                              Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com 
                              Time zone: CET: Central European Time
                               
                              Raven Canzeri, Global Director, Media Relations
                              Tel: +1 770-670-2524, e-mail: Raven.Canzeri@elekta.com
                              Time zone: ET: Eastern Time
                               
                              About Elekta
                              As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.

                              Attachments


                              Sweden SBTi Validation 2023 EN Final

                              Downloads

                              • Sweden SBTi Validation 2023 EN Final
                              • Products
                                • Radiation Therapy
                                • Stereotactic Radiosurgery
                                • Oncology Informatics
                                • Brachytherapy
                                • Neurosurgery
                                • Veterinary Radiation Therapy
                              • Services
                                • Elekta Care Customer Services
                                • Elekta Care 360
                                • Elekta Care Learning
                                • Elekta Care Community
                                • Elekta Partner Community
                              • Patients
                                • MR-Linac Treatment
                                • Brachytherapy Treatment
                                • Gamma Knife Treatment
                                • Radiation Therapy Treatment
                                • Treatment Centers
                              • Company
                                • Partnering with Elekta
                                • About us
                                • Sustainability
                                • Corporate Governance
                                • Investors
                                • Newsroom
                                • Careers at Elekta
                                • Country and regional pages
                                • Digital Product Security
                                • Offices
                              • Facebook
                              • LinkedIn
                              • Twitter
                              • Instagram
                              • Youtube
                              • ©2023 Elekta
                              • Legal notices
                              • Privacy policy
                              • Cookies
                              • Subscription center

                              Important Safety Information: Radiation therapy is not appropriate for all patients. Radiation treatments may cause side effects that can vary depending on the part of the body being treated. In some patients, they can be severe. Treatment sessions may vary in complexity and time. Refer to individual product labeling (instructions for use) for more complete information on product safety and effectiveness for its intended use.

                              © 2023 Elekta

                              • Legal notices
                              • Privacy policy
                              • Cookies
                              • Subscription center

                              Important Safety Information: Radiation therapy is not appropriate for all patients. Radiation treatments may cause side effects that can vary depending on the part of the body being treated. In some patients, they can be severe. Treatment sessions may vary in complexity and time. Refer to individual product labeling (instructions for use) for more complete information on product safety and effectiveness for its intended use.